期刊文献+

非梗死相关血管慢性完全闭塞对行急诊介入治疗的ST段抬高型心肌梗死患者预后的影响 被引量:6

Prognostic Impact of Chronic Total Occlusion on Non-infarct-related Artery in Patients of Acute ST-elevation Myocardial Infarction With Emergent Primary Percutaneous Coronary Intervention
在线阅读 下载PDF
导出
摘要 目的:分析非梗死相关血管慢性完全闭塞(CTO)对接受直接经皮冠状动脉介入治疗(PCI)的急性ST段抬高型心肌梗死(STEMI熄者预后的影响。方法:选择2010~01至2011-06连续在我院确诊急性STEMI并行早期直接PCI治疗的185例患者,分为非梗死相关血管无CTO组(无CTO组)和非梗死相关血管合并CTO组(CTO组),共150例患者完成了1年随访,主要终点为1年时因心绞痛、再次心肌梗死(MI)、心力衰竭而住院或再次血运重建以及心血管死亡。结果:(1)无CTO组160例(86.5%),CTO组25例(13.5%),CTO组患者糖尿病及冠状动脉三支血管病变的比例均显著高于无CTO组(40.0%vs20.0%,P=0.049;68.0%vs36.3%,P=0.003);CTO组左心室射血分数显著低于无CTO组[(40.0±20.1)%vs(51.3±15.3)%,P〈0.05],差异均有统计学意义。(2)CTO组患者6个月、1年的心血管死亡以及1年时的主要终点发生率均显著高于无CTO组(26.3%vs6.1%,P=0.013;31.6%vs8.4%,P=0.010;52.6%vs16.8%,P=0.001),差异均有统计学意义。(3)多因素分析显示,非梗死相关血管合并CTO[风险比(HR)=3.889,95%可信区间:1.239—4.206,P=0.0201、心原性休克(HR=3.229,95%可信区间:2.760~3.725,P=0.012)及冠状动脉三支血管病变(HR=2.008,95%可信区间:1.549~3.372,P=0.040)是行直接PCI的急性STEMI患者1年心血管死亡的独立预测因素。结论:非梗死相关血管存在CTO并接受直接PCI的急性STEMI患者多预后不良,非梗死相关血管合并CTO、心原性休克、冠状动脉三支血管病变是这类患者1年心血管死亡的独立预测因素。 Objective: To study the prognostic impact of chronic total occlusion (CTO) on non-infarct-related artery (non-IRA) in patients of acute ST-elevation myocardial infarction (STEMI) with emergent primary percutaneous coronary intervention (PCI). Methods: In this prospective study, a total of 185 consecutive acute STEMI patients received early stage primary PCI in our hospital from 2010-01to 2011-06 were enrolled. The patients were divided into 2 groups: non-CTO group, n=160 and CTO group, n=25. The patients were followed-up for 1 year and the primary endpoint events included the hospitalization for angina, re-MI, heart failure or revascularization and cardiac death. Results: (1) There were more patients with diabetes and three vessel disease in CTO group than those in non-CTO group (40.0 % vs 20.0 %, P=0.049) and (68.0 % vs 36.3 %, P= 0.003); LVEF in CTO group was lower than non-CTO group (40.0 ± 20.1% vs 51.3 + 15.3 %, P〈0.05). (2) The cardiac mortalities at 6-month and 1-year followed-up period were higher in CTO group than those in non-CTO group (26.3% vs 6.1%, P=0.013) and (31.6% vs 8.4%, P=0.010); 1-year primary endpoint events were higher in CTO group (52.6% vs 16.8%, P=0.001). (3) Multivariate regression analysis revealed that non-IRA combining CTO (HR=3.889, 95% CI: 1.239-4.206, P=0.020), cardiac shock (HR=3.229, 95% CI 2.760-3.725, P=0.012) and three vessel disease (HR=2.008, 95% CI: 1.549-3.372, P=0.040) were the independent predictors for 1-year mortality in patients of acute STEMI with primary PCI. Conclusion: Non-IRA combining CTO in STEMI patients with primary PCI are usually having poor prognosis.
机构地区 北京医院心内科
出处 《中国循环杂志》 CSCD 北大核心 2016年第1期20-24,共5页 Chinese Circulation Journal
关键词 心肌梗死 血管成形术 经腔 经皮冠状动脉 冠状动脉闭塞 预后 Acute myocardial infarction Percutaneous coronary intervention Chronic total occlusion Infarct related artery Prognosis
  • 相关文献

参考文献18

  • 1Stone GW, Kandzari DE, Mehran R, et al. Percutaneous recanalizationof chronically occluded coronary arteries: a consensus document: part I.Circulation, 2005,112: 2364-2372.
  • 2Tajstra M, Gasior M, Gieriotka PM, et al. Comparison of five-yearoutcomes of patients with and Without chronic total occlusion of non-infarct coronary artery after primary coronary intervention for ST-segment elevation acute myocardial infarction. Am J Cardiol, 2012,109: 208-213.
  • 3Van der Schaaf RJ, Vis MM, Sjauw KD, et al. Impact of multivesselcoronary disease on long-term mortality in patients with ST-elevationmyocardial infarction is due to the presence of a chronic totalocclusion. Am J Cardiol, 2006, 98: 1165-1169.
  • 4Hannan EL, Racz M, Holmes DR, et al. Impact of completeness ofpercutaneous coronary intervention revascularization on long-termoutcomes in the stent era. Circulation, 2006, 113: 2406-2412.
  • 5Hannan EL, Wu C, Walford G, et al. Incomplete revascularization inthe era of drug-eluting stents. Impact on adverse outcomes. J Am CollCardiol Intv, 2009,2: 17-25.
  • 6Kushner FG, Hand M, Smith SC Jr, et al. 2009 Focused Updates:ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction and ACC/AH A/SC Al Guidelines onPercutaneous Coronary Intervention: a report of the American Collegeof Cardiology Foundation/American Heart Association Task Force onPractice Guidelines. Circulation, 2009, 120: 2271-2306.
  • 7Ma YC, Li Z, Chen JH, et al. Modified glomerular filtration rateestimating equation for Chinese patients with chronic kidney disease. JAm Soc Nephrol, 2006,17: 2937-2944.
  • 8Van der Schaaf RJ, Timmer JR, Ottervanger JP, et al. Long-termimpact of multivessel disease on cause-specific mortality after ST-elevation myocardial infarction treated with reperfusion therapy. Heart,2006,92: 1760-1763.
  • 9Conde-Vela C, Moreno R, Hernandez R, et al. Cardiogenic shock atadmission in patients with multivessel disease and acute myocardialinfarction treated with percutaneous coronary intervention: relatedfactors. Int J Cardiol, 2007,123: 29-33.
  • 10Van der Schaaf RJ, Claessen BE, Vis MM, et al. Effect of multivesselcoronary disease with or without concurrent chronic total occlusionon one-year mortality in patients treated with primary percutaneouscoronary intervention for cardiogenic shock. Am J Cardiol, 2010, 105:955-959.

二级参考文献7

  • 1Buller CE,Dzavik V,Carere RG,et al.Primary stenting versus ballon angioplasty in occluded coronary arteries:the Tatal Occlusion Study of Canada(TOSCA).Circulation,1999,100:236-242.
  • 2Tamai H,Berger PB,Tsuchikane T,et al.Frequency and time course of rsocclusion and restenosis in coronary artery occlusions after balloon angioplasty versus Wiktor stent implantation:results from the Mayo-Japan Investigation for Chronic Total Occlusion trial.Am Heart J,2004,147:E9.
  • 3Werner GS,Krack A,Schwarz G,et al.Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents.J Am Coll Cardiol,2004,44:2301-2306.
  • 4Hoye A,Tanabe K,Lersus PA,et al.Significant reduction in restenosis after the use of sirolimus-eluting stems in the treatment of chronic total occlusion.J Am Coll Cardiol,2004,43:1954-1958.
  • 5Kelbak H,Helqvist S,Thuesen L,et al.Sirolimus versus bare metal stent implantation in patients with total coronary occlusions:Subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease(SCANDSTENT) trial.Am Heart J,2006,152:882-888.
  • 6Migliofini A,Moschi G,Vergara R,et al.Drug-eluting stent-supported pereutansous coronary intervention for chronic total coronary occlusion.Catheter Cardiovase Interv,2006,67:344-348.
  • 7Jang JS,Hong MK,Lee CW,et al.Comparison between sirolimus-and Paclitaxel-eluting stents for the treatment of chronic total occlusions.J Invasive Cardiology,2006,18:205-208.

同被引文献45

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部